Physicians' Academy for Cardiovascular Education

Changing the outlook for a chronic heart failure patient: Optimising RAASi treatment through long-term potassium control

Meeting report with presentation slides, videos and online CME of a PACE-CME symposium held during ESC 2020, The Digital Experience.

E-learning: Optimizing RAASi treatment through long-term potassium control

Online-CME - This course consists of 3 parts.
This course consists of 3 parts.

Three experts in this field discuss in three separate videos: the comorbidity burden in HF patients, the effect of hyperkalemia on use of RAASi and the enabling of RAASi therapy with potassium binders.

Introduction: Optimizing RAASi treatment through long-term potassium control

10' education - Oct. 22, 2020 - Prof. Peter van der Meer, MD
Prof. Van der Meer gives an introduction to the symposium about comorbidities in HF with a specific focus on hyperkalemia, that was held during the virtual ESC 2020 congress.

Prof. Van der Meer gives an introduction to the symposium about comorbidities in HF with a specific focus on hyperkalemia, that was held during the virtual ESC 2020 congress.

Novel potassium binders to improve management of chronic HF

10' education - Oct. 21, 2020 - Prof. Javed Butler, MD - Online CME
RAAS inhibitors can cause hyperkalemia in HF patients. Javed Butler explains how novel potassium binders may improve management of patients with chronic HF by continuation of RAASi.

RAAS inhibitors can cause hyperkalemia in HF patients leading to RAASi downtitration or discontinuation. Novel potassium binders may improve management of HF patients by continuation of RAASi.

Understanding risk of hyperkalemia in heart failure

10' education - Oct. 8, 2020 - Prof. Piotr Ponikowski, MD, PhD - Online CME
Prof. Ponikowski discusses the importance of optimization of RAASi treatment through long-term potassium control in HF patients.

Prof. Ponikowski discusses the importance of optimization of RAASi treatment through long-term potassium control in HF patients with hyperkalemia.

Heart failure, a multimorbid syndrome: An increasing challenge to manage

10' education - Sep. 21, 2020 - Prof. Carolyn Lam, MD, PhD - Online CME
Prof. Lam discusses important effects of comorbidities in HF patients and how these comorbidities may affect the use of treatments for HF.

Prof. Lam discusses important effects of comorbidities in HF patients and how these comorbidities may affect the use of treatments for HF.

Discussion: Optimizing RAASi treatment through long-term potassium control

Sep. 8, 2020

Expert discussion on optimizing RAASi treatment through long-term potassium control.

Changing the outlook for a chronic heart failure patient: Optimising RAASi treatment through long-term potassium control